Acrux heads to the Finnish
Thursday, 14 August, 2008
Acrux [ASX: ACR] has entered into a manufacturing alliance with the Finnish Orion Corporation.
Under the agreement, Orion will become the exclusive manufacturer for Acrux's Testosterone MD-Lotion, as well as a range of transdermal spray products under development.
Acrux retains the rights to supply the products to licensees in all territories.
Both parties will invest in additional equipment at Orion's manufacturing facility as part of the alliance.
Proposed Australian trial eyes up blood testing for Alzheimer's
Utilising networks of GPs across three states, a large-scale study intends on combining digital...
Applications open for $300K pandemic therapeutics fellowships
Applications are now open for the Cumming Global Centre for Pandemic Therapeutics' inaugural...
CTA granted for CAR-T cell therapy for multiple myeloma
The Therapeutic Goods Administration has granted Clinical Trial Approval for KMCAR T-cell...
